Our Grants

CIRM provides funding across five key areas: Infrastructure, Education, Discovery Research, Translational Research, and Clinical Research. By supporting projects at every stage of development, from initial discovery to clinical trials, CIRM drives progress in regenerative medicine and accelerates innovative therapies to patients.

Check out our portfolio of awards below. Click here to see a list of People We’ve Funded. Click here to see a list of our Funded Institutions.

All CIRM Grants

Search Filters »

Institution Researcher name Grant Type Grant Title Award Value
University of California, San Diego Dr. David A. Cheresh Basic Biology V CD61-driven stemness program in epithelial cancer $1,161,000
University of California, Berkeley Dr. Andrew Dillin Basic Biology V A Requirement for Protein Homeostasis in the Mediation of Stem Cell Health $1,034,100
Stanford University Xinnan Wang Basic Biology V Misregulated Mitophagy in Parkinsonian Neurodegeneration $1,174,943
University of Southern California Mark Salman Humayun Disease Team Therapy Development III Phase 1 Safety Assessment of CPCB-RPE1, hESC-derived RPE Cell Coated Parylene Membrane Implants, in Patients with Advanced Dry Age Related Macular Degeneration $16,339,827
University of California, Davis Peter Belafsky Disease Team Therapy Development III Tissue Engineered Recellularized Laryngotracheal Implants $3,181,162
University of California, Los Angeles Dr. Dennis J Slamon Disease Team Therapy Development III A Phase I dose escalation and expansion clinical trial of the novel first-in-class Polo-like Kinase 4 (PLK4) inhibitor, CFI-400945 in patients with advanced solid tumors $5,683,693
Stanford University Professor Irving L Weissman MD Disease Team Therapy Development III Clinical Investigation of a Humanized Anti-CD47 Antibody in Targeting Cancer Stem Cells in Hematologic Malignancies and Solid Tumors $6,505,568
University of California, Los Angeles Dr. Donald B. Kohn Disease Team Therapy Development III Clinical Trial of Stem Cell Gene Therapy for Sickle Cell Disease $10,351,535
University of California, San Diego Thomas J Kipps Disease Team Therapy Development III Therapeutic Eradication of Cancer Stem Cells with UC-961 (Cirmtuzumab) $4,179,598
Sangamo BioSciences, Inc. Dr. Fyodor D Urnov Strategic Partnership II A Treatment For Beta-thalassemia via High-Efficiency Targeted Genome Editing of Hematopoietic Stem Cells $2,760,540
Human BioMolecular Research Institute Dr. John R Cashman Ph.D. Patent Assistance Fund Awards Intellectual Property for Stem Cell-Related Inventions – HBRI $50,000
University of California, San Francisco Karin Immergluck PhD Patent Assistance Fund Awards Patent Assistance Fund Proposal – UCSF $87,257
University of California, Davis David McGee Patent Assistance Fund Awards CIRM Patent Prosecution Assistance Fund for Stem Cell Technologies – UCD $48,595
University of California, Santa Barbara Bernadette McCafferty Patent Assistance Fund Awards Intellectual Property in Regenerative Bioengineering from CIRM funded research in regenerative medicine at the University of California, Santa Barbara. $23,564
University of California, Irvine Ronnie Hanecak Patent Assistance Fund Awards CIRM Patent Assistance Fund Application – UCI $46,155
Scribe Therapeutics Maria Mirotsou Preclinical Stage Projects A First-in-Class CIRSPR-CasX Gene Editing Therapy for Lowering Lp(a) to Prevent Cardiovascular Events $12,714,480
4D Molecular Therapeutics, Inc. Dr Melissa Calton Preclinical Stage Projects Gene Therapy for Alpha-1 Anti-Trypsin Deficiency $5,916,702
AcuraStem Incorporated Mr. Samuel V. Alworth MS, MBA Preclinical Stage Projects Late-stage development of AS-241, an UNC13A Targeting Antisense Oligonucleotide treatment for Amyotrophic Lateral Sclerosis, for IND-enabling studies $7,500,000
Cure Rare Disease Dr. Tahseen Mozaffar Preclinical Stage Projects Advancement of a myotropic, liver-detargeting therapy for LGMD2i/R9 $7,350,596
Scribe Therapeutics Brett Staahl Preclinical Stage Projects A first-in-class CRISPR-CasX gene editor silencing APOC3 transcription for the treatment of Severe Hypertriglyceridemia $13,000,000
Savanna Biotherapeutics, Inc. Dr. Sunil Gandhi Ph.D Preclinical Stage Projects Microglia replacement therapy for CSF1R-related Leukoencephalopathy $12,993,456
Cedars-Sinai Medical Center Dr. David Joseph Lefer Preclinical Stage Projects TY1 and Semaglutide to Treat Cardiometabolic HFpEF $10,571,220
University of California, San Diego Dr Stephanie Cherqui Preclinical Stage Projects CRISPR/Cas9-mediated gene editing of Hematopoietic stem and progenitor cells for Friedreich’s ataxia $7,423,504
Cedars-Sinai Medical Center Dr. Alessandra Ciullo Preclinical Stage Projects Noncoding RNA drug TY2 for arrhythmogenic cardiomyopathy $10,419,929
Navega Therapeutics Ana Maria Moreno Preclinical Stage Projects Development of an AAV Epigenetic Gene Therapy for Intractable Chronic Pain Disorders $9,486,864
Scripps Health Dr. Darryl D. D’Lima Preclinical Stage Projects Stem Cell-Based Cartilage Tissue Regeneration $12,715,000
Stanford University Dr. Bertha Chen Preclinical Stage Projects Autologous iPSC-derived progenitor smooth muscle cells for treatment of urinary incontinence $7,499,999
Loma Linda University Hisham Abdel-Azim CCCE Grant Inland Empire and Desert Region CIRM Community Care Center of Excellence $9,000,000
Community Health System Haifaa Abdulhaq CCCE Grant Establishing a CIRM Community Care Center of Excellence in the Central Valley $8,996,101
Lundquist Institute for Biomedical Innovation at Harbor – UCLA Medical Center Christina Wang CCCE Grant South Los Angeles Community Center of Excellence for Regenerative Medicine $9,000,000
University of California, San Diego Jonathan Sebat ReMIND – Discovery Stage ReMIND Modeling the genetic basis of psychopathology in schizophrenia and autism $12,703,708
University of California, San Francisco Mercedes Paredes ReMIND – Discovery Stage ReMIND Multi-gene modulation to rescue CNS-associated microdeletion syndromes $6,253,897
University of California, Los Angeles Aparna Bhaduri ReMIND – Discovery Stage ReMIND Defining Neurovascular Metabolism in Neurodevelopmental and Neuropsychiatric Disorders $10,330,000
University of California, San Francisco Tomasz Nowakowski ReMIND – Discovery Stage ReMIND CIRM Center for Neuropsychiatric Stem Cell Proteomics $13,781,522
Scripps Research Institute Xin Jin ReMIND – Discovery Stage ReMIND Translational epigenomics: dissecting cell type-specific function of neuropsychiatric risk genes in vivo $11,376,314
Scripps Research Institute Stuart A Lipton ReMIND – Discovery Stage ReMIND Multiomic Studies of Idiopathic Intellectual Disability and Autism Spectrum Disorder (ID/ASD) $17,365,387
University of California, San Francisco Alex Pollen ReMIND – Discovery Stage ReMIND Deep phenotyping of human brain organoid models of autism spectrum disorder to unravel disease heterogeneity and develop biomarkers and treatments $12,297,272
Coast to Coast Conferences & Events Calli France Conference – 2026 CIRM Trainee Network Conference 2025 CIRM Trainee Networking Conference $413,145
University of Southern California Dr. Francesca Mariani Conference – 2026 CIRM Trainee Network Conference Manage the 2024 CIRM Annual Trainee Network Conference $348,626
EVERSANA Ms. Liana Rostamian Patient Support Program Patient Support Program to Improve Accessibility to Eligible CIRM-Trial Patients $2,485,000
Gladstone Institutes, J. David Dr. Bruce R. Conklin Shared Labs Grant – Enhancing/Expanding SRLs A Center for Stem Cell Disease Modeling and Therapeutics $3,999,997
Cedars-Sinai Medical Center Arun Sharma Shared Labs Grant – Enhancing/Expanding SRLs Shared Resource Laboratory for Advanced Stem Cell-Based Modeling $3,991,879
University of California, Santa Barbara Dr. Dennis O. Clegg Dr. Shared Labs Grant – Enhancing/Expanding SRLs Shared Resources Laboratory for Stem Cell-Based Modeling in Stem Cell Biology and Engineering $3,999,995
Salk Institute for Biological Studies Dr. Fred H Gage Shared Labs Grant – Enhancing/Expanding SRLs Shared Resource Laboratory for Stem Cell-Based Modeling: Resources for Exploring the Biological Underpinnings of Aging and Age-Associated Pathologies $3,641,064
University of Southern California Dr. Nils O. Lindstrom Shared Labs Grant – Enhancing/Expanding SRLs CIRM ASCEND Center – Advancing Stem Cell Education and Novel Discoveries $3,663,163
University of California, Los Angeles Dr. Kathrin Plath Dr. Shared Labs Grant – Enhancing/Expanding SRLs A modular automation approach to stem cell modeling to increase throughput, reproducibility and access $3,999,999
University of California, Irvine Craig Michael Walsh Shared Labs Grant – Enhancing/Expanding SRLs Shared Resources Laboratories to Enhance In Vitro Stem Cell Modeling and Training $3,641,396
Humboldt State University Sponsored Programs Foundation Dr Amy Sprowles Shared Labs Grant – Establishing SRLs Cal Poly Humboldt Shared Resource Laboratory for Human Stem Cell-Based Modeling (SRL-hSC) $4,399,888
University of California, Merced Dr. Kara E McCloskey Shared Labs Grant – Establishing SRLs UCM Resources for Expanding Stem cell-derived Tissues and Organs for Regenerative Engineering (RESTORE) $5,396,133
Lundquist Institute for Biomedical Innovation at Harbor – UCLA Medical Center Denise Al Alam Shared Labs Grant – Establishing SRLs Stem cell-based Parternship Resource for Investigating Human Diseases and Training (SPRINT) $5,400,000
1 … 19 20 21 22 23 24 25 26 27 28 29 30 31 32

How to Apply

Learn More

Explore CIRM-Funded Clinical Trials

Learn More

Managing Your Grant

Learn More

See our Active Awards Portfolio

Learn More